• Home
  • Medical Devices
Dynamics in Post-pandemic Global Obesity Treating Neuromodulation System Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Obesity Treating Neuromodulation System Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ663502 | No. of Pages: 138 | Category: Medical Devices
Publisher: GRD Survey | Date of Publish: Mar-2021 
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Obesity Treating Neuromodulation System market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Obesity Treating Neuromodulation System market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Vagus Nerve Stimulator

Splanchnic Nerve Stimulator

Deep Brain Stimulator

Spinal Cord Stimulator

Autonomous Nerve Stimulator

Others

Segmented by End User/Segment
Hospitals

Clinics

Ambulatory Surgical Centers

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
ReShape Lifesciences

Nuvectra

Nevro

Medtronic

Leptos Medical

Cyberonics

BioControl Medical

Abbott



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Obesity Treating Neuromodulation System Market Status and Forecast (2016-2027)
        1.3.2 Global Obesity Treating Neuromodulation System Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Obesity Treating Neuromodulation System Supply by Company
    2.1 Global Obesity Treating Neuromodulation System Sales Volume by Company
    2.2 Global Obesity Treating Neuromodulation System Sales Value by Company
    2.3 Global Obesity Treating Neuromodulation System Price by Company
    2.4 Obesity Treating Neuromodulation System Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Obesity Treating Neuromodulation System Market Status by Category
    3.1 Obesity Treating Neuromodulation System Category Introduction
        3.1.1 Vagus Nerve Stimulator

        3.1.2 Splanchnic Nerve Stimulator

        3.1.3 Deep Brain Stimulator

        3.1.4 Spinal Cord Stimulator

        3.1.5 Autonomous Nerve Stimulator

        3.1.6 Others
    3.2 Global Obesity Treating Neuromodulation System Market by Category
        3.2.1 Global Obesity Treating Neuromodulation System Sales Volume by Category (2016-2021)
        3.2.2 Global Obesity Treating Neuromodulation System Sales Value by Category (2016-2021)
        3.2.3 Global Obesity Treating Neuromodulation System Price by Category (2016-2021)
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional Obesity Treating Neuromodulation System Market Status by End User/Segment
    4.1 Obesity Treating Neuromodulation System Segment by End User/Segment
        4.1.1 Hospitals

        4.1.2 Clinics

        4.1.3 Ambulatory Surgical Centers
    4.2 Global Obesity Treating Neuromodulation System Market by End User/Segment
        4.2.1 Global Obesity Treating Neuromodulation System Sales Volume by End User/Segment (2016-2021)
        4.2.2 Global Obesity Treating Neuromodulation System Sales Value by End User/Segment (2016-2021)
        4.2.3 Global Obesity Treating Neuromodulation System Price by End User/Segment (2016-2021)
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global Obesity Treating Neuromodulation System Market Status by Region
    5.1 Global Obesity Treating Neuromodulation System Market by Region
        5.1.1 Global Obesity Treating Neuromodulation System Sales Volume by Region
        5.1.2 Global Obesity Treating Neuromodulation System Sales Value by Region
    5.2 North America Obesity Treating Neuromodulation System Market Status
    5.3 Europe Obesity Treating Neuromodulation System Market Status
    5.4 Asia Pacific Obesity Treating Neuromodulation System Market Status
    5.5 Central & South America Obesity Treating Neuromodulation System Market Status
    5.6 Middle East & Africa Obesity Treating Neuromodulation System Market Status
6 North America Obesity Treating Neuromodulation System Market Status
    6.1 North America Obesity Treating Neuromodulation System Market by Country
        6.1.1 North America Obesity Treating Neuromodulation System Sales Volume by Country (2016-2021)
        6.1.2 North America Obesity Treating Neuromodulation System Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Obesity Treating Neuromodulation System Market Status
    7.1 Europe Obesity Treating Neuromodulation System Market by Country
        7.1.1 Europe Obesity Treating Neuromodulation System Sales Volume by Country (2016-2021)
        7.1.2 Europe Obesity Treating Neuromodulation System Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Obesity Treating Neuromodulation System Market Status
   8.1 Asia Pacific Obesity Treating Neuromodulation System Market by Country
        8.1.1 Asia Pacific Obesity Treating Neuromodulation System Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific Obesity Treating Neuromodulation System Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Obesity Treating Neuromodulation System Market Status
    9.1 Central & South America Obesity Treating Neuromodulation System Market by Country
        9.1.1 Central & South America Obesity Treating Neuromodulation System Sales Volume by Country (2016-2021)
        9.1.2 Central & South America Obesity Treating Neuromodulation System Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Obesity Treating Neuromodulation System Market Status
    10.1 Middle East & Africa Obesity Treating Neuromodulation System Market by Country
        10.1.1 Middle East & Africa Obesity Treating Neuromodulation System Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa Obesity Treating Neuromodulation System Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Obesity Treating Neuromodulation System Manufacturing Cost Analysis
    11.5 Obesity Treating Neuromodulation System Sales Channel and Distributors Analysis
        11.5.1 Obesity Treating Neuromodulation System Sales Channel
        11.5.2 Obesity Treating Neuromodulation System Distributors
    11.6 Obesity Treating Neuromodulation System Downstream Major Buyers
12 Global Obesity Treating Neuromodulation System Market Forecast by Category and by End User/Segment
    12.1 Global Obesity Treating Neuromodulation System Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global Obesity Treating Neuromodulation System Forecast by Category
        12.2.1 Global Obesity Treating Neuromodulation System Sales Volume Forecast by Category
        12.2.2 Global Obesity Treating Neuromodulation System Sales Value Forecast by Category
        12.2.3 Global Obesity Treating Neuromodulation System Price Forecast by Category
    12.3 Global Obesity Treating Neuromodulation System Forecast by End User/Segment
        12.3.1 Global Obesity Treating Neuromodulation System Sales Volume Forecast by End User/Segment
        12.3.2 Global Obesity Treating Neuromodulation System Sales Value Forecast by End User/Segment
        12.3.3 Global Obesity Treating Neuromodulation System Price Forecast by End User/Segment
13 Global Obesity Treating Neuromodulation System Market Forecast by Region/Country
    13.1 Global Obesity Treating Neuromodulation System Market Forecast by Region (2022-2027)
        13.1.1 Global Obesity Treating Neuromodulation System Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global Obesity Treating Neuromodulation System Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 ReShape Lifesciences

        14.1.1 Company Information
        14.1.2 Obesity Treating Neuromodulation System Product Introduction
        14.1.3 ReShape Lifesciences
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 Nuvectra

        14.2.1 Company Information
        14.2.2 Obesity Treating Neuromodulation System Product Introduction
        14.2.3 Nuvectra
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 Nevro

        14.3.1 Company Information
        14.3.2 Obesity Treating Neuromodulation System Product Introduction
        14.3.3 Nevro
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Medtronic

        14.4.1 Company Information
        14.4.2 Obesity Treating Neuromodulation System Product Introduction
        14.4.3 Medtronic
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Leptos Medical

        14.5.1 Company Information
        14.5.2 Obesity Treating Neuromodulation System Product Introduction
        14.5.3 Leptos Medical
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Cyberonics

        14.6.1 Company Information
        14.6.2 Obesity Treating Neuromodulation System Product Introduction
        14.6.3 Cyberonics
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.6.4 SWOT Analysis
    14.7 BioControl Medical

        14.7.1 Company Information
        14.7.2 Obesity Treating Neuromodulation System Product Introduction
        14.7.3 BioControl Medical
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.7.4 SWOT Analysis
    14.8 Abbott

        14.8.1 Company Information
        14.8.2 Obesity Treating Neuromodulation System Product Introduction
        14.8.3 Abbott
 Obesity Treating Neuromodulation System Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.8.4 SWOT Analysis
15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com